Method for treating amyloid disease
US9770496B2 · kind B2 · utility
0Cited by
20References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2016 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Mar 21, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for treating human amyloid disease by administration of modified Aβ peptide immunogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.